E
Eikon Therapeutics Inc
NASDAQ:EIKN
Eikon Therapeutics Inc
NASDAQ:EIKN
Price:
9.01
USD
-5.16%
Market Closed
Market Cap:
$487.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
Eikon Therapeutics Inc
NASDAQ:EIKN
|
US |
Cash Flow Statement
Cash Flow Statement
Eikon Therapeutics Inc
Eikon Therapeutics Inc
Currency: USD
| Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|
| Operating Cash Flow | ||||
| Net Income |
(242)
|
(244)
|
(324)
|
|
| Depreciation & Amortization |
11
|
15
|
19
|
|
| Stock-Based Compensation |
10
|
12
|
18
|
|
| Other Non-Cash Items |
30
|
13
|
39
|
|
| Cash Interest Paid |
0
|
0
|
1
|
|
| Change in Working Capital |
10
|
81
|
78
|
|
| Cash from Operating Activities |
(191)
N/A
|
(135)
+29%
|
(189)
-40%
|
|
| Investing Cash Flow | ||||
| Capital Expenditures |
(29)
|
(85)
|
(47)
|
|
| Other Items |
165
|
236
|
(135)
|
|
| Cash from Investing Activities |
137
N/A
|
151
+11%
|
(181)
N/A
|
|
| Financing Cash Flow | ||||
| Net Issuance of Common Stock |
106
|
0
|
352
|
|
| Cash from Financing Activities |
106
N/A
|
0
-100%
|
352
+144 184%
|
|
| Change in Cash | ||||
| Net Change in Cash |
52
N/A
|
17
-68%
|
(18)
N/A
|
|
| Free Cash Flow | ||||
| Free Cash Flow |
(219)
N/A
|
(220)
0%
|
(235)
-7%
|
|
Switch to:
Switch to:
See Also
Discover More
